Clinical Trial Update: Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ranibizumab with peripheral scatter laser in diabetic macular edema with peripheral nonperfusion. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Retina Associates of Florida, P.A. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2015-03-05